MyAverix Finance
IC · Healthcare
Oculis Holding AG (OCS)
Biotechnology
Oculis Holding AG (OCS) is listed on IC in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for OCS
Oculis Holding AG (OCS) — FAQ
What is OCS's P/E ratio?
The price-to-earnings (P/E) ratio for Oculis Holding AG (OCS) is 25.00 (data as of 2026-05-24).
Does Oculis Holding AG pay a dividend?
Dividend yield is not available in the current snapshot for Oculis Holding AG (OCS). Check the MyAverix Finance app for the latest dividend data.
What sector is Oculis Holding AG in?
Oculis Holding AG (OCS) is classified in the Healthcare sector (Biotechnology industry).
What exchange is OCS listed on?
OCS is listed on IC.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.